Christine Hanna, PA
Medical · Jacksonville, FLNPI 1639470370
Payments from drug & device makers
Across 159 payments — averaging $50.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$6K
- Regeneron Healthcare Solutions, Inc.$519
- GSK$278
- Sanofi$144
- AstraZeneca$137
- CSL Behring$102
- plus $416 from 10 others
What the payments were for
- Consulting fees$4,22052%
- Travel & lodging$1,28016%
- Food & beverage$2,42830%
- Education$1101%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 78 | $6,443 |
| Regeneron Healthcare Solutions, Inc. | 23 | $519 |
| GSK | 16 | $278 |
| Sanofi | 6 | $144 |
| AstraZeneca | 8 | $137 |
| CSL Behring | 6 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Incyte Corporation | 3 | $58 |
| Pharming Healthcare, Inc. | 3 | $58 |
| Amgen | 2 | $46 |
| Grifols USA, LLC | 3 | $46 |
| Pfizer | 2 | $33 |
| Greer Laboratories, Inc. | 1 | $29 |
| Optinose US, Inc. | 1 | $25 |
| Kaleo, Inc. | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $17 |
How this compares
$8,039 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 33 | $198,716 |
| XolairOmalizumab | 19 | $69,933 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 13 | $50,068 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $15,631 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $12,760 |
| Ipratropium Bromide | 114 | $3,425 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $2,544 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,281 |
| Azelastine Hcl | 73 | $2,234 |
| Epinephrine | 14 | $2,165 |
| Fluticasone Propionate | 95 | $1,844 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $843 |
| Wixela InhubFluticasone Propion/Salmeterol | 15 | $812 |
| Montelukast Sodium | 69 | $529 |
| Omeprazole | 33 | $387 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $102 | $198,71633 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $85 | $50,06813 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Arnuity Ellipta | $278 | $30,67355 claims |
| Hikma Pharmaceuticals USAEpinephrine | $17 | $2,16514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,031 medical providers in Florida.
Other medical in Jacksonville
- Eric PonderJacksonville$67K
- Kristen DixonJacksonville$54K
- Amanda MichaudJacksonville$45K
- Paul DuffJacksonville$35K
- Ina SansonJacksonville$15K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.